GRILLI, MASSIMO
 Distribuzione geografica
Continente #
EU - Europa 9.017
Totale 9.017
Nazione #
IT - Italia 9.017
Totale 9.017
Città #
Genova 6.280
Rapallo 1.103
Genoa 994
Vado Ligure 611
Bordighera 29
Totale 9.017
Nome #
Blockade of stress-induced increase of glutamate release in the rat prefrontal/frontal cortex by agomelatine involves synergy between melatonergic and 5-HT2C receptor-dependent pathways 157
Dangerous liaisons between beta-amyloid and cholinergic neurotransmission 148
Chronic nicotine exposure selectively activates a carrier-mediated release of endogenous glutamate and aspartate from rat hippocampal synaptosomes 147
In vitro exposure to nicotine induces endocytosis of presynaptic AMPA receptors modulating dopamine release in rat Nucleus Accumbens nerve terminals 145
Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in rat hippocampus 144
Functional interaction between presynaptic nicotinic and D2 receptors on dopaminergic nerve endings of rat and mouse nucleus accumbens 137
Presynaptic nicotinic receptors evoke endogenous glutamate and aspartate release from hippocampal synaptosomes by way of distinct coupling mechanisms 136
Somatostatin inhibits glutamate release from mouse cerebrocortical nerve endings through presynaptic sst2 receptors linked to the adenylyl cyclase-protein kinase A pathway 136
Hippocampal AMPA autoreceptors positively coupled to NMDA autoreceptors traffic in a constitutive manner and undergo adaptative changes following enriched environment training. 133
Prophylactic versus therapeutic fingolimod: Restoration of presynaptic defects in mice suffering from experimental autoimmune encephalomyelitis 132
Beta Amyloid Differently Modulate Nicotinic and Muscarinic Receptor Subtypes which Stimulate in vitro and in vivo the Release of Glycine in the Rat Hippocampus 131
Aß influences nicotinic-stimulated release of both excitatory and inhibitory neurotransmitters in rat hippocampus 129
Salvinorin A modulates the neurotransmitters release from different mouse brain areas through presynaptic metabotropic receptors activation. 129
Presynaptic c-Jun N-terminal Kinase 2 regulates NMDA receptor-dependent glutamate release 128
Chronic nicotine differentially affects the function of nicotinic receptor subtypes regulating neurotransmitter release 126
Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus 121
Effects of the neoclerodane Hardwickiic acid on the presynaptic opioid receptors which modulate noradrenaline and dopamine release in mouse central nervous system 121
Different presynaptic nicotinic receptor subtypes modulate in vivo and in vitro the release of glycine in the rat hippocampus 118
Acute β-Amyloid Administration Disrupts the Cholinergic Control of Dopamine Release in the Nucleus Accumbens 116
Dual Effect of Beta-Amyloid on α7 and α4β2 Nicotinic Receptors Controlling the Release of Glutamate, Aspartate and GABA in Rat Hippocampus 116
Ellagic acid a multi-target bioactive compound for drug discovery in CNS? A narrative review 116
Beta Amyloid and cholinergic system: old actors for new different roles 115
Microdispersions of ellagic acid and pomegranate extracts as new potential nutraceutical ingredients 115
Presynaptic nicotinic α7 and non-α7 receptors stimulate endogenous GABA release from rat hippocampal synaptosomes through two mechanisms of action. 110
< i> In vitro exposure to nicotine modulate the function of presynaptic NMDA receptors present on dopaminergic terminals in rat Nucleus Accumbens 110
Release-enhancing presynaptic muscarinic and nicotinic receptors coexist and interact on dopaminergic nerve endings of rat nucleus accumbens 109
Exposure to an enriched environment selectively increases the functional response of the pre-synaptic NMDA receptors which modulate noradrenaline release in mouse hippocampus 106
Prolonged nicotine exposure down-regulates presynaptic \NMDA\ receptors in dopaminergic terminals of the rat nucleus accumbens 106
Nicotinic modulation of glutamate receptor function at nerve terminal level: a fine-tuning of synaptic signals 106
P2X7 receptors exert a permissive role on the activation of release- enhancing presynaptic alpha7 nicotinic receptors co-existing on rat neocortex glutamatergic terminals 105
Presynaptic nicotinic receptors modulating neurotransmitter release in the Central Nervous System: functional interactions with other coexisting receptors 104
The human immunodeficiency virus-1 protein Tat and its discrete fragments evoke selective release of acetylcholine from human and rat cerebrocortical terminals through species-specific mechanisms 102
Stimulus-selective neuromodulatory action of beta-amyloid 101
5-HT2A-mGlu2/3 receptor complex in rat spinal cord glutamatergic nerve endings: A 5-HT2Ato mGlu2/3 signalling to amplify presynaptic mechanism of auto-control of glutamate exocytosis 100
Salvinorin A exerts opposite presynaptic controls on neurotransmitter exocytosis from mouse brain nerve terminals 98
Beta-amyloid short- and long-term synaptic entanglement 97
Chronic nicotine causes functional upregulation of ionotropic glutamate receptors mediating hippocampal noradrenaline and striatal dopamine release 95
Presynaptic modulation of cholinergic neurotransmission 91
A new specific neuronal modulatory effect of nicotine: the functional cross talk between nicotinic and glutamate receptors 91
Characterization of GABAA receptors expressed in glial cell membranes of adult mouse neorcortex using a Xenopus oocyte microtransplantation expression system 90
Isolation of hydroxyoctaprenyl-1’,4’-hydroquinone, a new octaprenylhydroquinone from the marine sponge Sarcotragus spinosulus and evaluation of its pharmacological activity on acetylcholine and glutamate release in the rat Central Nervous System. 90
Memantine-sulfur containing antioxidant conjugates as potential prodrugs to improve the treatment of Alzheimer’s disease 89
null 89
β-amyloid differently modulates the function of nAChRs which stimulate the release of glutamate, aspartate, glycine and GABA in rat hippocampus 89
NMDA-mediated modulation of dopamine release is modified in rat prefrontal cortex and nucleus accumbens after chronic nicotine treatment 88
Nicotine exerts a permissive role on NMDA receptor function in hippocampal noradrenergic terminals 88
Presynaptic, release-regulating mGlu2-preferring and mGlu3-preferring autoreceptors in CNS: pharmacological profiles and functional roles in demyelinating disease 88
β-amyloid impairs the nicotinic-stimulated neurotransmitter release in rat hippocampus in absence of neurotoxicity 86
Pre-exposure to nicotine induces endocytosis of presynaptic AMPA receptors modulating dopamine release in rat Nucleus Accumbens synaptosomes 86
Nicotinic and muscarinic cholinergic receptors coexist on GABAergic nerve endings in the mouse striatum and interact in modulating GABA release 85
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats 83
In vitro pre-exposure to nicotine: modulation of presynaptic NMDA receptors present on dopaminergic terminals in rat Nucleus Accumbens. 81
Bud-derivatives, a Novel Source of Polyphenols and How Different Extraction Processes Affect Their Composition 81
Nicotine has permissive role on the activation of metabotropic glutamate 5 receptor coexisting with nicotinic receptors on rat hippocampal noradrenergic nerve terminals. 81
βamyloid differently regulates the function of nAChRs which stimulate the release of glutamate, aspartate, glycine and GABA in rat hippocampus 80
Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites 5-hydroxyindole and kynurenate in mouse brain 80
Neuromodulatory actions of beta-amyloid on DA release 79
In vitro exposure to nicotine modulates the function of presynaptic NMDA receptors present on dopaminergic terminals in rat Nucleus Accumbens 79
The Functional cross-talk between nicotinic and glutamatergic receptors on dopaminergic nerve terminals in the rat nucleus accumbens 77
Presynaptic mGlu7 receptors control GABA release in mouse hippocampus 77
STUDIO DEGLI EFFETTI DI MOLECOLE ESTRATTE DA SALVIE COME MODULATORIDELLA NEUROTRASMISSIONE CENTRALE 75
Presynaptic GluA2-containing AMPA autoreceptors functionally coupled to NMDA autoreceptors: receptor trafficking and adaptative changes following exposure to environmental enrichment 75
Nicotine pre-exposure modulates NMDA receptors function in dopaminergic terminals of the rat nucleus accumbens 74
Nicotinic a7 and non-a7 receptors modulate endogenous aminoacids release from rat hippocampal synaptosomes 73
Specific neuromodulatory actions of beta-amyloid: novel mechanisms 72
Salviae neoclerodane derivatives differently affect catecholamine release in mammal brains: comparison with Salvinorin 72
Different Effects of Beta Amyloid on α7 and α4β2 Nicotinic Receptors Controlling the Release of Aminoacids in Rat Hippocampal nerve endings 72
Evidence that alpha7 nicotinic receptor modulates glutamate release from mouse neocortical gliosomes 71
Chronic nicotine treatment differentially affects the function of presynaptic NMDA receptors modulating dopamine release from rat prefrontal cortex and nucleus accumbens 71
5HT2A- mGlu2/3 receptor-receptor interaction in the spinal cord of adult rats: new pharmacological approaches to treat hyperglutamatergicity 71
Salvinorin A controls the release of different neurotransmitters in distinct rodent brain areas by acting at presynaptic metabotropic membrane receptors. 67
Effects of soluble beta-amyloid on the release of neurotransmitters from rat brain synaptosomes 67
Specific neuromodulatory actions of amyloid-beta on dopamine release in rat nucleus accumbens and caudate putamen 65
Neuroinflammation in Aged Brain: Impact of the Oral Administration of Ellagic Acid Microdispersion 64
Specific inhibitory effects of beta-amyloid on presynaptic muscarinic receptor subtypes modulating neurotransmitter release in the rat nucleus accumbens 63
The 3Rs: reduction and refinement through a multivariate statistical analysis approach in a behavioural study to unveil anxiolytic effects of natural extracts of Tilia Tomentosa. 63
Gender and age dependency of the effects of Bud extracts from Tilia tomentosa Moench in central nervous system 62
Presynaptic nicotinic and D2 receptors coexist and functionally interact on dopaminergic nerve endings of rat and mouse nucleus accumbens 61
Receptor-receptors functional cross-talk: new evidences on nicotine-NMDA receptor interaction 61
Release regulating mGlu2-preferring and mGlu3 preferring autoreceptors in CNS 60
The 3Rs: Reduction and refinement through a multivariate statistical analysis approach in a behavioural study to unveil anxiolytic effects of natural extracts of Tilia tomentosa 59
Presynaptic GlytT1 transporter, AMPA and NMDA autoreceptors in mouse hippocampal glutamatergic nerve terminals: functional coupling, receptor trafficking and adaptative changes due to enriched environment training 58
Pharmacological profiles and functional roles of presynaptic, release regulating mGlu2-preferring and mGlu3-preferring autoreceptors and their role in demyelinating disease. 58
Nicotinic alpha7 receptor activation selectively potentiates the function of NMDA receptors in glutamatergic terminals of the nucleus accumbens 56
Pharmacological profiles and functional roles of presynaptic, release regulating mGlu2/3 autoreceptors in the spinal cord. 56
Effects of bud extracts from Tilia tomentosa Moench in central nervous system of mice: gender and age- dependency 48
The promnesic effects of Tilia tomentosa bud extracts on old male mice 48
New advances in the knowledge of the 5HT2A / mGlu2/3 receptor-receptor functional cross talk in mammal central nervous system 47
Video tracking analysis of behavioral scores: The Finnover experience 46
Specific neuromodulatory actions of beta-amyloid: novel mechanisms. 43
GLI EFFETTI ANSIOLITICI E PROMNESICI DEGLI ESTRATTI DI TILIA TOMENTOSA: UNO STUDIO PRECLINICO 41
Functional interaction between presynaptic receptors on dopaminergic and noradrenergic nerve terminals of the rat central nervous system 40
Inhibitory effects of beta-amyloid 1-40 on the nicotine-evoked neurotransmitters release in the rat central nervous system. 39
Functional interaction between presynaptic nicotinic and NMDA receptors on dopaminergic and noradrenergic nerve terminals of the rat central nervous system 39
Receptor-receptors functional cross-talk: a focus on nicotine NMDA receptor interaction. 38
Nicotinic α7 receptor activation induces NMDA receptors trafficking in glutamatergic terminals of the nucleus accumbens 38
Nicotine pre-exposure selectively modulates the function of NMDA receptors present on glutamatergic terminals. 38
Prolonged "in vitro" exposure to nicotine modulate the function of presynaptic GABA B autoreceptors present on gabaergic nerve endings in rat hippocampus 37
Complement tunes glutamate release and supports synaptic impairments in an animal model of multiple sclerosis 35
In vitro exposure to nicotinic agonists modulates the function of NMDA receptors present on glutamatergic and GABAergic nerve endings in rat nucleus Accumbens. 35
Totale 8.651
Categoria #
all - tutte 30.069
article - articoli 18.445
book - libri 0
conference - conferenze 11.161
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 463
Totale 60.138


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.827 0 0 0 0 163 227 324 126 194 425 280 88
2020/2021693 46 49 40 68 51 63 49 59 89 55 61 63
2021/20221.294 28 90 128 116 73 59 65 313 43 119 63 197
2022/20231.346 132 122 20 89 204 228 20 99 237 7 173 15
2023/2024775 46 86 21 115 84 145 46 38 21 33 48 92
2024/2025652 63 159 56 154 220 0 0 0 0 0 0 0
Totale 9.206